SpringerLink
Log in

Epigenetic Alterations of Viral and Cellular Genomes in EBV-Infected Cells

  • Chapter
  • First Online:
Epigenetics - A Different Way of Looking at Genetics

Part of the book series: Epigenetics and Human Health ((EHH))

  • 1721 Accesses

Abstract

Epstein–Barr virus (EBV), a human herpesvirus, replicates in oropharyngeal epithelial cells and establishes latency in memory B cells. A series of neoplasms including lymphomas, carcinomas, and leiomyosarcomas also carry latent EBV genomes. The viral episomes are subject to epigenetic modifications, including DNA methylation, histone modifications, and formation of chromatin loops in various host cells. These epigenetic alterations control the host cell-dependent activity of latent EBV promoters. Viral methylomes, i.e., the CpG methylation patterns of the latent episomes, also vary, depending on the host cell phenotype. Although there are distinct, invariably unmethylated regions in EBV genomes, like sequences within oriP, the latent origin of EBV replication, the overall level methylation of the viral episomes is high in Burkitt’s lymphomas (BLs) and nasopharyngeal carcinomas (NPCs), whereas lymphoblastoid cell lines (LCLs) carry hypomethylated viral genomes. Latency products, including nuclear and transmembrane proteins expressed in EBV-infected cells, interact either directly or indirectly with the epigenetic machinery of the host cell and may modify its epigenotype and gene expression pattern. Such epigenetic alterations may play a role in the development of EBV-associated neoplasms. Recently, the methylomes of EBV-positive BLs, NPCs, and EBV-associated gastric carcinomas (EBVaGCs) were thoroughly analyzed. These tumors exhibited a CpG island methylator phenotype (CIMP) characterized with a dysregulation of gene expression due to the silencing of key cellular promoters. In contrast, a complete genomic bisulfite sequence analysis of quiescent B cells and in vitro EBV-infected B lymphoblasts revealed a profound, genome-wide demethylation suggesting that the epigenetic events associated with B-cell immortalization, a possible counterpart of the development of posttransplant lymphoproliferative disease (PTLD), differ from the epigenetic dysregulation observed in BLs, NPCs, and EBVaGCs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Accardi R, Fathallah I, Gruffat H, Mariggio G, Le Calvez-Kelm F, Voegele C, Bartosch B, Hernandez-Vargas H, McKay J, Sylla BS, Manet E, Tommasino M (2013) Epstein-Barr virus transforming protein LMP-1 alters B cells gene expression by promoting accumulation of the oncoprotein DeltaNp73alpha. PLoS Pathog 9, e1003186

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Al Tabaa Y, Tuaillon E, Bollore K, Foulongne V, Petitjean G, Seigneurin JM, Duperray C, Desgranges C, Vendrell JP (2009) Functional Epstein-Barr virus reservoir in plasma cells derived from infected peripheral blood memory B cells. Blood 113:604–611

    Article  CAS  PubMed  Google Scholar 

  • Alazard N, Gruffat H, Hiriart E, Sergeant A, Manet E (2003) Differential hyperacetylation of histones H3 and H4 upon promoter-specific recruitment of EBNA2 in Epstein-Barr virus chromatin. J Virol 77:8166–8172

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Altiok E, Minarovits J, Hu LF, Contreras-Brodin B, Klein G, Ernberg I (1992) Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6. Proc Natl Acad Sci U S A 89:905–909

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Au WY, Pang A, Chan EC, Chu KM, Shek TW, Kwong YL (2005) Epstein-Barr virus-related gastric adenocarcinoma: an early secondary cancer post hemopoietic stem cell transplantation. Gastroenterology 129:2058–2063

    Article  PubMed  Google Scholar 

  • Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA (1998) EBV persistence in memory B cells in vivo. Immunity 9:395–404

    Article  CAS  PubMed  Google Scholar 

  • Bakos A, Banati F, Koroknai A, Takacs M, Salamon D, Minarovits-Kormuta S, Schwarzmann F, Wolf H, Niller HH, Minarovits J (2007) High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1. Virus Genes 35:195–202

    Article  CAS  PubMed  Google Scholar 

  • Banati F, Koroknai A, Salamon D, Takacs M, Minarovits-Kormuta S, Wolf H, Niller HH, Minarovits J (2008) CpG-methylation silences the activity of the RNA polymerase III transcribed EBER-1 promoter of Epstein-Barr virus. FEBS Lett 582:705–709

    Article  CAS  PubMed  Google Scholar 

  • Bashir RM, Harris NL, Hochberg FH, Singer RM (1989) Detection of Epstein-Barr virus in CNS lymphomas by in-situ hybridization. Neurology 39:813–817

    Article  CAS  PubMed  Google Scholar 

  • Bergbauer M, Kalla M, Schmeinck A, Gobel C, Rothbauer U, Eck S, Benet-Pages A, Strom TM, Hammerschmidt W (2010) CpG-methylation regulates a class of Epstein-Barr virus promoters. PLoS Pathog 6, e1001114

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Bhende PM, Seaman WT, Delecluse HJ, Kenney SC (2005) BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186. J Virol 79:7338–7348

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Birdwell CE, Queen KJ, Kilgore PC, Rollyson P, Trutschl M, Cvek U, Scott RS (2014) Genome-wide DNA methylation as an epigenetic consequence of Epstein-Barr virus infection of immortalized keratinocytes. J Virol 88:11442–11458

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Bodescot M, Perricaudet M, Farrell PJ (1987) A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus. J Virol 61:3424–3430

    CAS  PubMed  PubMed Central  Google Scholar 

  • Bornkamm GW, Hammerschmidt W (2001) Molecular virology of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 356:437–459

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Borza CM, Hutt-Fletcher LM (2002) Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med 8:594–599

    Article  CAS  PubMed  Google Scholar 

  • Burke LJ, Zhang R, Bartkuhn M, Tiwari VK, Tavoosidana G, Kurukuti S, Weth C, Leers J, Galjart N, Ohlsson R, Renkawitz R (2005) CTCF binding and higher order chromatin structure of the H19 locus are maintained in mitotic chromatin. EMBO J 24:3291–3300

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Burkitt D (1962) A children’s cancer dependent on climatic factors. Nature 194:232–234

    Article  CAS  PubMed  Google Scholar 

  • Caliskan M, Cusanovich DA, Ober C, Gilad Y (2011) The effects of EBV transformation on gene expression levels and methylation profiles. Hum Mol Genet 20:1643–1652

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Capello D, Rossi D, Gaidano G (2005) Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis. Hematol Oncol 23:61–67

    Article  PubMed  Google Scholar 

  • Challouf S, Ziadi S, Zaghdoudi R, Ksiaa F, Ben Gacem R, Trimeche M (2012) Patterns of aberrant DNA hypermethylation in nasopharyngeal carcinoma in Tunisian patients. Clin Chim Acta 413:795–802

    Article  CAS  PubMed  Google Scholar 

  • Chan KH, Tam JS, Peiris JS, Seto WH, Ng MH (2001) Epstein-Barr virus (EBV) infection in infancy. J Clin Virol 21:57–62

    Article  CAS  PubMed  Google Scholar 

  • Chang MS, Lee HS, Kim HS, Kim SH, Choi SI, Lee BL, Kim CW, Kim YI, Yang M, Kim WH (2003) Epstein-Barr virus and microsatellite instability in gastric carcinogenesis. J Pathol 199:447–452

    Article  PubMed  Google Scholar 

  • Chau CM, Lieberman PM (2004) Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. J Virol 78:12308–12319

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chinnadurai G (2009) The transcriptional corepressor CtBP: a foe of multiple tumor suppressors. Cancer Res 69:731–734

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cohen JI, Wang F, Mannick J, Kieff E (1989) Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci U S A 86:9558–9562

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Coppotelli G, Mughal N, Callegari S, Sompallae R, Caja L, Luijsterburg MS, Dantuma NP, Moustakas A, Masucci MG (2013) The Epstein-Barr virus nuclear antigen-1 reprograms transcription by mimicry of high mobility group A proteins. Nucleic Acids Res 41:2950–2962

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cui Y, Gao D, Linghu E, Zhan Q, Chen R, Brock MV, Herman JG, Guo M (2015) Epigenetic changes and functional study of HOXA11 in human gastric cancer. Epigenomics 7:201–213

    Article  CAS  PubMed  Google Scholar 

  • Dai W, Cheung AK, Ko JM, Cheng Y, Zheng H, Ngan RK, Ng WT, Lee AW, Yau CC, Lee VH, Lung ML (2015) Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma. Cancer Med 4(7):1079–1090

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Day L, Chau CM, Nebozhyn M, Rennekamp AJ, Showe M, Lieberman PM (2007) Chromatin profiling of Epstein-Barr virus latency control region. J Virol 81:6389–6401

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • De Witt Hamer PC, Mir SE, Noske D, Van Noorden CJ, Wurdinger T (2011) WEE1 kinase targeting combined with DNA-damaging cancer therapy catalyzes mitotic catastrophe. Clin Cancer Res 17:4200–4207

    Article  PubMed  CAS  Google Scholar 

  • Dickerson SJ, **ng Y, Robinson AR, Seaman WT, Gruffat H, Kenney SC (2009) Methylation-dependent binding of the epstein-barr virus BZLF1 protein to viral promoters. PLoS Pathog 5, e1000356

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Dillner J, Kallin B, Ehlin-Henriksson B, Timar L, Klein G (1985) Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA. Int J Cancer 35:359–366

    Article  CAS  PubMed  Google Scholar 

  • Draborg AH, Duus K, Houen G (2013) Epstein-Barr virus in systemic autoimmune diseases. Clin Dev Immunol 2013:535738

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Dutton A, Woodman CB, Chukwuma MB, Last JI, Wei W, Vockerodt M, Baumforth KR, Flavell JR, Rowe M, Taylor AM, Young LS, Murray PG (2007) Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells. Blood 109:2597–2603

    Article  CAS  PubMed  Google Scholar 

  • Ehlin-Henriksson B, Zou JZ, Klein G, Ernberg I (1999) Epstein-Barr virus genomes are found predominantly in IgA-positive B cells in the blood of healthy carriers. Int J Cancer 83:50–54

    Article  CAS  PubMed  Google Scholar 

  • Enomoto S, Maekita T, Tsukamoto T, Nakajima T, Nakazawa K, Tatematsu M, Ichinose M, Ushijima T (2007) Lack of association between CpG island methylator phenotype in human gastric cancers and methylation in their background non-cancerous gastric mucosae. Cancer Sci 98:1853–1861

    Article  CAS  PubMed  Google Scholar 

  • Epstein MA, Achong BG, Barr YM (1964) Virus particles in cultured lymphoblasts from Burkitt’s Lymphoma. Lancet 1:702–703

    Article  CAS  PubMed  Google Scholar 

  • Ernberg I, Falk K, Minarovits J, Busson P, Tursz T, Masucci MG, Klein G (1989) The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus. J Gen Virol 70(Pt 11):2989–3002

    Article  CAS  PubMed  Google Scholar 

  • Falk KI, Szekely L, Aleman A, Ernberg I (1998) Specific methylation patterns in two control regions of Epstein-Barr virus latency: the LMP-1-coding upstream regulatory region and an origin of DNA replication (oriP). J Virol 72:2969–2974

    CAS  PubMed  PubMed Central  Google Scholar 

  • Fejer G, Koroknai A, Banati F, Gyory I, Salamon D, Wolf H, Niller HH, Minarovits J (2008) Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus. J Gen Virol 89:1364–1370

    Article  CAS  PubMed  Google Scholar 

  • Fernandez AF, Rosales C, Lopez-Nieva P, Grana O, Ballestar E, Ropero S, Espada J, Melo SA, Lujambio A, Fraga MF, Pino I, Javierre B, Carmona FJ, Acquadro F, Steenbergen RD, Snijders PJ, Meijer CJ, Pineau P, Dejean A, Lloveras B, Capella G, Quer J, Buti M, Esteban JI, Allende H, Rodriguez-Frias F, Castellsague X, Minarovits J, Ponce J, Capello D, Gaidano G, Cigudosa JC, Gomez-Lopez G, Pisano DG, Valencia A, Piris MA, Bosch FX, Cahir-McFarland E, Kieff E, Esteller M (2009) The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res 19:438–451

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Frappier L (2012) The Epstein-Barr Virus EBNA1 Protein. Scientifica (Cairo) 2012:438204

    Google Scholar 

  • Frappier L, O’Donnell M (1991) Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus. Proc Natl Acad Sci U S A 88:10875–10879

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gerle B, Koroknai A, Fejer G, Bakos A, Banati F, Szenthe K, Wolf H, Niller HH, Minarovits J, Salamon D (2007) Acetylated histone H3 and H4 mark the upregulated LMP2A promoter of Epstein-Barr virus in lymphoid cells. J Virol 81:13242–13247

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Glaser SL, Lin RJ, Stewart SL, Ambinder RF, Jarrett RF, Brousset P, Pallesen G, Gulley ML, Khan G, O’Grady J, Hummel M, Preciado MV, Knecht H, Chan JK, Claviez A (1997) Epstein-Barr virus-associated Hodgkin’s disease: epidemiologic characteristics in international data. Int J Cancer 70:375–382

    Article  CAS  PubMed  Google Scholar 

  • Gratama JW, Oosterveer MA, Zwaan FE, Lepoutre J, Klein G, Ernberg I (1988) Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proc Natl Acad Sci U S A 85:8693–8696

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Greenspan D, Greenspan JS, Hearst NG, Pan LZ, Conant MA, Abrams DI, Hollander H, Levy JA (1987) Relation of oral hairy leukoplakia to infection with the human immunodeficiency virus and the risk of develo** AIDS. J Infect Dis 155:475–481

    Article  CAS  PubMed  Google Scholar 

  • Guelen L, Pagie L, Brasset E, Meuleman W, Faza MB, Talhout W, Eussen BH, de Klein A, Wessels L, de Laat W, van Steensel B (2008) Domain organization of human chromosomes revealed by map** of nuclear lamina interactions. Nature 453:948–951

    Article  CAS  PubMed  Google Scholar 

  • Hammerschmidt W, Sugden B (1988) Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 55:427–433

    Article  CAS  PubMed  Google Scholar 

  • Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, McDonald OG, Wen B, Wu H, Liu Y, Diep D, Briem E, Zhang K, Irizarry RA, Feinberg AP (2011) Increased methylation variation in epigenetic domains across cancer types. Nat Genet 43:768–775

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hansen KD, Sabunciyan S, Langmead B, Nagy N, Curley R, Klein G, Klein E, Salamon D, Feinberg AP (2014) Large-scale hypomethylated blocks associated with Epstein-Barr virus-induced B-cell immortalization. Genome Res 24:177–184

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hanto DW, Frizzera G, Gajl-Peczalska KJ, Simmons RL (1985) Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 39:461–472

    Article  CAS  PubMed  Google Scholar 

  • Harth-Hertle ML, Scholz BA, Erhard F, Glaser LV, Dolken L, Zimmer R, Kempkes B (2013) Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9. PLoS Pathog 9, e1003638

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • He D, Zhang YW, Zhang NN, Zhou L, Chen JN, Jiang Y, Shao CK (2015) Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas. Med Oncol 32:525

    Google Scholar 

  • Henkel T, Ling PD, Hayward SD, Peterson MG (1994) Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science 265:92–95

    Article  CAS  PubMed  Google Scholar 

  • Henle W, Henle G (1979) The virus as the etiologic agent of infectious mononucleosis. In: Epstein MA, Achong BG (eds) The Epstein-Barr virus. Springer, Berlin, pp 293–320

    Google Scholar 

  • Hennessy K, Heller M, van Santen V, Kieff E (1983) Simple repeat array in Epstein-Barr virus DNA encodes part of the Epstein-Barr nuclear antigen. Science 220:1396–1398

    Article  CAS  PubMed  Google Scholar 

  • Hernando H, Shannon-Lowe C, Islam AB, Al-Shahrour F, Rodriguez-Ubreva J, Rodriguez-Cortez VC, Javierre BM, Mangas C, Fernandez AF, Parra M, Delecluse HJ, Esteller M, Lopez-Granados E, Fraga MF, Lopez-Bigas N, Ballestar E (2013) The B cell transcription program mediates hypomethylation and overexpression of key genes in Epstein-Barr virus-associated proliferative conversion. Genome Biol 14:R3

    Article  PubMed  PubMed Central  Google Scholar 

  • Hernando H, Islam AB, Rodriguez-Ubreva J, Forne I, Ciudad L, Imhof A, Shannon-Lowe C, Ballestar E (2014) Epstein-Barr virus-mediated transformation of B cells induces global chromatin changes independent to the acquisition of proliferation. Nucleic Acids Res 42:249–263

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hino R, Uozaki H, Murakami N, Ushiku T, Shinozaki A, Ishikawa S, Morikawa T, Nakaya T, Sakatani T, Takada K, Fukayama M (2009) Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res 69:2766–2774

    Article  CAS  PubMed  Google Scholar 

  • Hjalgrim H, Askling J, Rostgaard K, Hamilton-Dutoit S, Frisch M, Zhang JS, Madsen M, Rosdahl N, Konradsen HB, Storm HH, Melbye M (2003) Characteristics of Hodgkin’s lymphoma after infectious mononucleosis. N Engl J Med 349:1324–1332

    Article  CAS  PubMed  Google Scholar 

  • Hofelmayr H, Strobl LJ, Stein C, Laux G, Marschall G, Bornkamm GW, Zimber-Strobl U (1999) Activated mouse Notch1 transactivates Epstein-Barr virus nuclear antigen 2-regulated viral promoters. J Virol 73:2770–2780

    CAS  PubMed  PubMed Central  Google Scholar 

  • Honess RW, Gompels UA, Barrell BG, Craxton M, Cameron KR, Staden R, Chang YN, Hayward GS (1989) Deviations from expected frequencies of CpG dinucleotides in herpesvirus DNAs may be diagnostic of differences in the states of their latent genomes. J Gen Virol 70(Pt 4):837–855

    Article  CAS  PubMed  Google Scholar 

  • Hsieh JJ, Henkel T, Salmon P, Robey E, Peterson MG, Hayward SD (1996) Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2. Mol Cell Biol 16:952–959

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hu LF, Minarovits J, Cao SL, Contreras-Salazar B, Rymo L, Falk K, Klein G, Ernberg I (1991) Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5′-flanking region. J Virol 65:1558–1567

    CAS  PubMed  PubMed Central  Google Scholar 

  • Hutt-Fletcher LM (2007) Epstein-Barr virus entry. J Virol 81:7825–7832

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jiwa NM, Kanavaros P, De Bruin PC, van der Valk P, Horstman A, Vos W, Mullink H, Walboomers JM, Meijer CJ (1993) Presence of Epstein-Barr virus harbouring small and intermediate-sized cells in Hodgkin’s disease. Is there a relationship with Reed-Sternberg cells? J Pathol 170:129–136

    Article  CAS  PubMed  Google Scholar 

  • Johannsen E, Koh E, Mosialos G, Tong X, Kieff E, Grossman SR (1995) Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. J Virol 69:253–262

    CAS  PubMed  PubMed Central  Google Scholar 

  • Jones CH, Hayward SD, Rawlins DR (1989) Interaction of the lymphocyte-derived Epstein-Barr virus nuclear antigen EBNA-1 with its DNA-binding sites. J Virol 63:101–110

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kalla M, Schmeinck A, Bergbauer M, Pich D, Hammerschmidt W (2010) AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome. Proc Natl Acad Sci U S A 107:850–855

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kaneda A, Matsusaka K, Aburatani H, Fukayama M (2012) Epstein-Barr virus infection as an epigenetic driver of tumorigenesis. Cancer Res 72:3445–3450

    Article  CAS  PubMed  Google Scholar 

  • Kang GH, Lee S, Kim WH, Lee HW, Kim JC, Rhyu MG, Ro JY (2002) Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol 160:787–794

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kempkes B, Pawlita M, Zimber-Strobl U, Eissner G, Laux G, Bornkamm GW (1995) Epstein-Barr virus nuclear antigen 2-estrogen receptor fusion proteins transactivate viral and cellular genes and interact with RBP-J kappa in a conditional fashion. Virology 214:675–679

    Article  CAS  PubMed  Google Scholar 

  • Klein G, Ernberg I (2007) Effects on apoptosis, cell cycle and transformation, and comparative aspects of EBV with other known DNA tumor viruses. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (eds) Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge

    Google Scholar 

  • Kosak ST, Skok JA, Medina KL, Riblet R, Le Beau MM, Fisher AG, Singh H (2002) Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development. Science 296:158–162

    Article  CAS  PubMed  Google Scholar 

  • Kreck B, Richter J, Ammerpohl O, Barann M, Esser D, Petersen BS, Vater I, Murga Penas EM, Bormann Chung CA, Seisenberger S, Lee Boyd V, Smallwood S, Drexler HG, Macleod RA, Hummel M, Krueger F, Hasler R, Schreiber S, Rosenstiel P, Franke A, Siebert R (2013) Base-pair resolution DNA methylome of the EBV-positive Endemic Burkitt lymphoma cell line DAUDI determined by SOLiD bisulfite-sequencing. Leukemia 27:1751–1753

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Leonard S, Wei W, Anderton J, Vockerodt M, Rowe M, Murray PG, Woodman CB (2011) Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin’s lymphoma. J Virol 85:9568–9577

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG, Masucci MG (1995) Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:685–688

    Article  CAS  PubMed  Google Scholar 

  • Li C, Shi Z, Zhang L, Huang Y, Liu A, ** Y, Yu Y, Bai J, Chen D, Gendron C, Liu X, Fu S (2010) Dynamic changes of territories 17 and 18 during EBV-infection of human lymphocytes. Mol Biol Rep 37:2347–2354

    Article  CAS  PubMed  Google Scholar 

  • Li L, Zhang Y, Fan Y, Sun K, Su X, Du Z, Tsao SW, Loh TK, Sun H, Chan AT, Zeng YX, Chan WY, Chan FK, Tao Q (2014) Characterization of the nasopharyngeal carcinoma methylome identifies aberrant disruption of key signaling pathways and methylated tumor suppressor genes. Epigenomics 7:155–173

    Article  PubMed  CAS  Google Scholar 

  • Liang Q, Yao X, Tang S, Zhang J, Yau TO, Li X, Tang CM, Kang W, Lung RW, Li JW, Chan TF, **ng R, Lu Y, Lo KW, Wong N, To KF, Yu C, Chan FK, Sung JJ, Yu J (2014) Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer. Gastroenterology 147:1350–1362.e1354

    Article  CAS  PubMed  Google Scholar 

  • Lo KW, Chung GT, To KF (2012) Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. Semin Cancer Biol 22:79–86

    Article  CAS  PubMed  Google Scholar 

  • Longnecker R, Kieff E, Cohen JI (2013) Epstein Barr virus. In: Knipe DM, Howley PM (eds) Fields virology, 6th edn. Lippincott Williams & Wilkins, Philadelphia, PA, pp 1898–1959

    Google Scholar 

  • Magrath I (1990) The pathogenesis of Burkitt’s lymphoma. Adv Cancer Res 55:133–270

    Article  CAS  PubMed  Google Scholar 

  • Martin-Subero JI, Ammerpohl O, Bibikova M, Wickham-Garcia E, Agirre X, Alvarez S, Bruggemann M, Bug S, Calasanz MJ, Deckert M, Dreyling M, Du MQ, Durig J, Dyer MJ, Fan JB, Gesk S, Hansmann ML, Harder L, Hartmann S, Klapper W, Kuppers R, Montesinos-Rongen M, Nagel I, Pott C, Richter J, Roman-Gomez J, Seifert M, Stein H, Suela J, Trumper L, Vater I, Prosper F, Haferlach C, Cruz Cigudosa J, Siebert R (2009a) A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms. PLoS One 4, e6986

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Martin-Subero JI, Kreuz M, Bibikova M, Bentink S, Ammerpohl O, Wickham-Garcia E, Rosolowski M, Richter J, Lopez-Serra L, Ballestar E, Berger H, Agirre X, Bernd HW, Calvanese V, Cogliatti SB, Drexler HG, Fan JB, Fraga MF, Hansmann ML, Hummel M, Klapper W, Korn B, Kuppers R, Macleod RA, Moller P, Ott G, Pott C, Prosper F, Rosenwald A, Schwaenen C, Schubeler D, Seifert M, Sturzenhofecker B, Weber M, Wessendorf S, Loeffler M, Trumper L, Stein H, Spang R, Esteller M, Barker D, Hasenclever D, Siebert R, Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche, K (2009b) New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood 113:2488–2497

    Article  CAS  PubMed  Google Scholar 

  • Masucci MG, Contreras-Salazar B, Ragnar E, Falk K, Minarovits J, Ernberg I, Klein G (1989) 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt’s lymphoma line rael. J Virol 63:3135–3141

    CAS  PubMed  PubMed Central  Google Scholar 

  • Matsusaka K, Kaneda A, Nagae G, Ushiku T, Kikuchi Y, Hino R, Uozaki H, Seto Y, Takada K, Aburatani H, Fukayama M (2011) Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes. Cancer Res 71:7187–7197

    Article  CAS  PubMed  Google Scholar 

  • McClellan MJ, Wood CD, Ojeniyi O, Cooper TJ, Kanhere A, Arvey A, Webb HM, Palermo RD, Harth-Hertle ML, Kempkes B, Jenner RG, West MJ (2013) Modulation of enhancer loo** and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming. PLoS Pathog 9, e1003636

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Middeldorp JM, Brink AA, van den Brule AJ, Meijer CJ (2003) Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders. Crit Rev Oncol Hematol 45:1–36

    Article  PubMed  Google Scholar 

  • Miller G (1990) The switch between latency and replication of Epstein-Barr virus. J Infect Dis 161:833–844

    Article  CAS  PubMed  Google Scholar 

  • Miller G, El-Guindy A, Countryman J, Ye J, Gradoville L (2007) Lytic cycle switches of oncogenic human gammaherpesviruses. Adv Cancer Res 97:81–109

    Article  CAS  PubMed  Google Scholar 

  • Minarovits J (2006) Epigenotypes of latent herpesvirus genomes. Curr Top Microbiol Immunol 310:61–80

    CAS  PubMed  Google Scholar 

  • Minarovits J, Minarovits-Kormuta S, Ehlin-Henriksson B, Falk K, Klein G, Ernberg I (1991) Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA. J Gen Virol 72(Pt 7):1591–1599

    Article  CAS  PubMed  Google Scholar 

  • Minarovits J, Hu LF, Marcsek Z, Minarovits-Kormuta S, Klein G, Ernberg I (1992) RNA polymerase III-transcribed EBER 1 and 2 transcription units are expressed and hypomethylated in the major Epstein-Barr virus-carrying cell types. J Gen Virol 73(Pt 7):1687–1692

    Article  CAS  PubMed  Google Scholar 

  • Navari M, Fuligni F, Laginestra MA, Etebari M, Ambrosio MR, Sapienza MR, Rossi M, De Falco G, Gibellini D, Tripodo C, Pileri SA, Leoncini L, Piccaluga PP (2014) Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus. Front Microbiol 5:728

    Article  PubMed  PubMed Central  Google Scholar 

  • Nemerow GR, Moore MD, Cooper NR (1990) Structure and function of the B-lymphocyte Epstein-Barr virus/C3d receptor. Adv Cancer Res 54:273–300

    Article  CAS  PubMed  Google Scholar 

  • Network CGAR (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513:202–209

    Article  CAS  Google Scholar 

  • Niedobitek G, Deacon EM, Young LS, Herbst H, Hamilton-Dutoit SJ, Pallesen G (1991) Epstein-Barr virus gene expression in Hodgkin’s disease. Blood 78:1628–1630

    CAS  PubMed  Google Scholar 

  • Niller HH, Minarovits J (2012) Similarities between the Epstein-Barr virus (EBV) nuclear protein EBNA1 and the pioneer transcription factor FoxA: is EBNA1 a “bookmarking” oncoprotein that alters the host cell epigenotype? Pathogens 1:37–51

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Niller HH, Salamon D, Ilg K, Koroknai A, Banati F, Schwarzmann F, Wolf H, Minarovits J (2004) EBV-associated neoplasms: alternative pathogenetic pathways. Med Hypotheses 62:387–391

    Article  CAS  PubMed  Google Scholar 

  • Niller HH, Wolf H, Minarovits J (2008) Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Autoimmunity 41:298–328

    Article  CAS  PubMed  Google Scholar 

  • Niller HH, Wolf H, Minarovits J (2011) Viral hit and run-oncogenesis: genetic and epigenetic scenarios. Cancer Lett 305:200–217

    Article  CAS  PubMed  Google Scholar 

  • Niller HH, Banati F, Ay E, Minarovits J (2012) Epigenetic changes in virus-associated neoplasms. In: Minarovits J, Niller HH (eds) Patho-epigenetics of disease. Springer, New York, NY, pp 179–225

    Chapter  Google Scholar 

  • Niller HH, Banati F, Minarovits J (2014a) Epigenetic alterations in nasopharyngeal carcinoma and Epstein-Barr virus (EBV) associated gastric carcinoma: a lesson in contrasts. J Nasopharyngeal Carcinoma 1, e9

    Google Scholar 

  • Niller HH, Szenthe K, Minarovits J (2014b) Epstein-Barr virus-host cell interactions: an epigenetic dialog? Front Genet 5:367

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Niller HH, Tarnai Z, Decsi G, Zsedenyi A, Banati F, Minarovits J (2014c) Role of epigenetics in EBV regulation and pathogenesis. Future Microbiol 9:747–756

    Article  CAS  PubMed  Google Scholar 

  • Nilsson K, Klein G, Henle W, Henle G (1971) The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int J Cancer 8:443–450

    Article  CAS  PubMed  Google Scholar 

  • Nolis IK, McKay DJ, Mantouvalou E, Lomvardas S, Merika M, Thanos D (2009) Transcription factors mediate long-range enhancer-promoter interactions. Proc Natl Acad Sci U S A 106:20222–20227

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nonoyama M, Kawai Y, Pagano JS (1975) Detection of Epstein-Barr virus DNA in human tumors. Bibl Haematol (40):577–583

    Google Scholar 

  • Ohno S, Luka J, Lindahl T, Klein G (1977) Identification of a purified complement-fixing antigen as the Epstein-Barr-virus determined nuclear antigen (EBNA) by its binding to metaphase chromosomes. Proc Natl Acad Sci U S A 74:1605–1609

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ott G, Ott MM, Feller AC, Seidl S, Muller-Hermelink HK (1992) Prevalence of Epstein-Barr virus DNA in different T-cell lymphoma entities in a European population. Int J Cancer 51:562–567

    Article  CAS  PubMed  Google Scholar 

  • Ott G, Kalla J, Ott MM, Muller-Hermelink HK (1997) The Epstein-Barr virus in malignant non-Hodgkin’s lymphoma of the upper aerodigestive tract. Diagn Mol Pathol 6:134–139

    Article  CAS  PubMed  Google Scholar 

  • Paliwal S, Ho N, Parker D, Grossman SR (2012) CtBP2 promotes human cancer cell migration by transcriptional activation of Tiam1. Genes Cancer 3:481–490

    PubMed  PubMed Central  Google Scholar 

  • Paschos K, Smith P, Anderton E, Middeldorp JM, White RE, Allday MJ (2009) Epstein-Barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim. PLoS Pathog 5, e1000492

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Paschos K, Parker GA, Watanatanasup E, White RE, Allday MJ (2012) BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV. Nucleic Acids Res 40:7233–7246

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Polvino-Bodnar M, Kiso J, Schaffer PA (1988) Mutational analysis of Epstein-Barr virus nuclear antigen 1 (EBNA 1). Nucleic Acids Res 16:3415–3435

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pope JH, Horne MK, Scott W (1968) Transformation of foetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus. Int J Cancer 3:857–866

    Article  CAS  PubMed  Google Scholar 

  • Portal D, Rosendorff A, Kieff E (2006) Epstein-Barr nuclear antigen leader protein coactivates transcription through interaction with histone deacetylase 4. Proc Natl Acad Sci U S A 103:19278–19283

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Portal D, Zhao B, Calderwood MA, Sommermann T, Johannsen E, Kieff E (2011) EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding. Proc Natl Acad Sci U S A 108:7808–7813

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Portal D, Zhou H, Zhao B, Kharchenko PV, Lowry E, Wong L, Quackenbush J, Holloway D, Jiang S, Lu Y, Kieff E (2013) Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2. Proc Natl Acad Sci U S A 110:18537–18542

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Radkov SA, Bain M, Farrell PJ, West M, Rowe M, Allday MJ (1997) Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21. J Virol 71:8552–8562

    CAS  PubMed  PubMed Central  Google Scholar 

  • Reedman BM, Klein G (1973) Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 11:499–520

    Article  CAS  PubMed  Google Scholar 

  • Reisman D, Sugden B (1986) trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol Cell Biol 6:3838–3846

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rickinson AB, Epstein MA, Crawford DH (1975) Absence of infectious Epstein-Barr virus in blood in acute infectious mononucleosis. Nature 258:236

    Article  CAS  PubMed  Google Scholar 

  • Rickinson AB, Young LS, Rowe M (1987) Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J Virol 61:1310–1317

    CAS  PubMed  PubMed Central  Google Scholar 

  • Robertson KD, Manns A, Swinnen LJ, Zong JC, Gulley ML, Ambinder RF (1996) CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt’s lymphoma and Hodgkin’s disease. Blood 88:3129–3136

    CAS  PubMed  Google Scholar 

  • Rogatsch H, Bonatti H, Menet A, Larcher C, Feichtinger H, Dirnhofer S (2000) Epstein-Barr virus-associated multicentric leiomyosarcoma in an adult patient after heart transplantation: case report and review of the literature. Am J Surg Pathol 24:614–621

    Article  CAS  PubMed  Google Scholar 

  • Rowe M, Raithatha S, Shannon-Lowe C (2014) Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions. J Virol 88:12065–12076

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Salamon D, Takacs M, Ujvari D, Uhlig J, Wolf H, Minarovits J, Niller HH (2001) Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus. J Virol 75:2584–2596

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Salamon D, Takacs M, Schwarzmann F, Wolf H, Minarovits J, Niller HH (2003) High-resolution methylation analysis and in vivo protein-DNA binding at the promoter of the viral oncogene LMP2A in B cell lines carrying latent Epstein-Barr virus genomes. Virus Genes 27:57–66

    Article  CAS  PubMed  Google Scholar 

  • Salamon D, Banati F, Koroknai A, Ravasz M, Szenthe K, Bathori Z, Bakos A, Niller HH, Wolf H, Minarovits J (2009) Binding of CCCTC-binding factor in vivo to the region located between Rep* and C-promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activity. J Gen Virol 90(Pt 5):1183–1189

    Article  CAS  PubMed  Google Scholar 

  • Sarkari F, Sanchez-Alcaraz T, Wang S, Holowaty MN, Sheng Y, Frappier L (2009) EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication. PLoS Pathog 5, e1000624

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Savard M, Belanger C, Tardif M, Gourde P, Flamand L, Gosselin J (2000) Infection of primary human monocytes by Epstein-Barr virus. J Virol 74:2612–2619

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schaefer BC, Woisetschlaeger M, Strominger JL, Speck SH (1991) Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Proc Natl Acad Sci U S A 88:6550–6554

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schneider R, Grosschedl R (2007) Dynamics and interplay of nuclear architecture, genome organization, and gene expression. Genes Dev 21:3027–3043

    Article  CAS  PubMed  Google Scholar 

  • Shibata D, Weiss LM (1992) Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 140:769–774

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sinclair AJ (2013) Epigenetic control of Epstein-Barr virus transcription – relevance to viral life cycle? Front Genet 4:161

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Sivachandran N, Sarkari F, Frappier L (2008) Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. PLoS Pathog 4, e1000170

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS (1984) Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 310:1225–1230

    Article  CAS  PubMed  Google Scholar 

  • Skalska L, White RE, Franz M, Ruhmann M, Allday MJ (2010) Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP. PLoS Pathog 6, e1000951

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Sompallae R, Callegari S, Kamranvar SA, Masucci MG (2010) Transcription profiling of Epstein-Barr virus nuclear antigen (EBNA)-1 expressing cells suggests targeting of chromatin remodeling complexes. PLoS One 5, e12052

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Stankiewicz TR, Gray JJ, Winter AN, Linseman DA (2014) C-terminal binding proteins: central players in development and disease. Biomol Concepts 5:489–511

    CAS  PubMed  Google Scholar 

  • Takacs M, Myohanen S, Altiok E, Minarovits J (1998) Analysis of methylation patterns in the regulatory region of the latent Epstein-Barr virus promoter BCR2 by automated fluorescent genomic sequencing. Biol Chem 379:417–422

    Article  CAS  PubMed  Google Scholar 

  • Takacs M, Banati F, Koroknai A, Segesdi J, Salamon D, Wolf H, Niller HH, Minarovits J (2010) Epigenetic regulation of latent Epstein-Barr virus promoters. Biochim Biophys Acta 1799:228–235

    Article  CAS  PubMed  Google Scholar 

  • Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872

    Article  CAS  PubMed  Google Scholar 

  • Takano Y, Saegusa M, Masuda M, Mikami T, Okayasu I (1997) Apoptosis, proliferative activity and Bcl-2 expression in Epstein-Barr-virus-positive non-Hodgkin’s lymphomas. J Cancer Res Clin Oncol 123:395–401

    Article  CAS  PubMed  Google Scholar 

  • Tang M, Lautenberger JA, Gao X, Sezgin E, Hendrickson SL, Troyer JL, David VA, Guan L, McIntosh CE, Guo X, Zheng Y, Liao J, Deng H, Malasky M, Kessing B, Winkler CA, Carrington M, De The G, Zeng Y, O’Brien SJ (2012) The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove. PLoS Genet 8, e1003103

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tao Q, Robertson KD (2003) Stealth technology: how Epstein-Barr virus utilizes DNA methylation to cloak itself from immune detection. Clin Immunol 109:53–63

    Article  CAS  PubMed  Google Scholar 

  • Taylor AL, Marcus R, Bradley JA (2005) Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol 56:155–167

    Article  PubMed  Google Scholar 

  • Tempera I, Wiedmer A, Dheekollu J, Lieberman PM (2010) CTCF prevents the epigenetic drift of EBV latency promoter Qp. PLoS Pathog 6, e1001048

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Tempera I, Klichinsky M, Lieberman PM (2011) EBV latency types adopt alternative chromatin conformations. PLoS Pathog 7, e1002180

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Toyota M, Ahuja N, Suzuki H, Itoh F, Ohe-Toyota M, Imai K, Baylin SB, Issa JP (1999) Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 59:5438–5442

    CAS  PubMed  Google Scholar 

  • Tsai CN, Tsai CL, Tse KP, Chang HY, Chang YS (2002) The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci U S A 99:10084–10089

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tsai CL, Li HP, Lu YJ, Hsueh C, Liang Y, Chen CL, Tsao SW, Tse KP, Yu JS, Chang YS (2006) Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling. Cancer Res 66:11668–11676

    Article  CAS  PubMed  Google Scholar 

  • Tsao SW, Tsang CM, To KF, Lo KW (2015) The role of Epstein-Barr virus in epithelial malignancies. J Pathol 235:323–333

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tse KP, Su WH, Chang KP, Tsang NM, Yu CJ, Tang P, See LC, Hsueh C, Yang ML, Hao SP, Li HY, Wang MH, Liao LP, Chen LC, Lin SR, Jorgensen TJ, Chang YS, Shugart YY (2009) Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. Am J Hum Genet 85:194–203

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tsoukas CD, Lambris JD (1988) Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies. Eur J Immunol 18:1299–1302

    Article  CAS  PubMed  Google Scholar 

  • Ushijima T (2007) Epigenetic field for cancerization. J Biochem Mol Biol 40:142–150

    Article  CAS  PubMed  Google Scholar 

  • Ushiku T, Chong JM, Uozaki H, Hino R, Chang MS, Sudo M, Rani BR, Sakuma K, Nagai H, Fukayama M (2007) p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer 120:60–66

    Article  CAS  PubMed  Google Scholar 

  • Vento-Tormo R, Rodriguez-Ubreva J, Lisio LD, Islam AB, Urquiza JM, Hernando H, Lopez-Bigas N, Shannon-Lowe C, Martinez N, Montes-Moreno S, Piris MA, Ballestar E (2014) NF-kappaB directly mediates epigenetic deregulation of common microRNAs in Epstein-Barr virus-mediated transformation of B-cells and in lymphomas. Nucleic Acids Res 42:11025–11039

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vo QN, Geradts J, Gulley ML, Boudreau DA, Bravo JC, Schneider BG (2002) Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation. J Clin Pathol 55:669–675

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Waltzer L, Logeat F, Brou C, Israel A, Sergeant A, Manet E (1994) The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements. EMBO J 13:5633–5638

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wang L, Grossman SR, Kieff E (2000) Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter. Proc Natl Acad Sci U S A 97:430–435

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang H, Zou J, Zhao B, Johannsen E, Ashworth T, Wong H, Pear WS, Schug J, Blacklow SC, Arnett KL, Bernstein BE, Kieff E, Aster JC (2011) Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells. Proc Natl Acad Sci U S A 108:14908–14913

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang K, Yuen ST, Xu J, Lee SP, Yan HH, Shi ST, Siu HC, Deng S, Chu KM, Law S, Chan KH, Chan AS, Tsui WY, Ho SL, Chan AK, Man JL, Foglizzo V, Ng MK, Chan AS, Ching YP, Cheng GH, **e T, Fernandez J, Li VS, Clevers H, Rejto PA, Mao M, Leung SY (2014) Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet 46:573–582

    Article  CAS  PubMed  Google Scholar 

  • Weinreb M, Day PJ, Niggli F, Powell JE, Raafat F, Hesseling PB, Schneider JW, Hartley PS, Tzortzatou-Stathopoulou F, Khalek ER, Mangoud A, El-Safy UR, Madanat F, Al Sheyyab M, Mpofu C, Revesz T, Rafii R, Tiedemann K, Waters KD, Barrantes JC, Nyongo A, Riyat MS, Mann JR (1996) The role of Epstein-Barr virus in Hodgkin’s disease from different geographical areas. Arch Dis Child 74:27–31

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wen B, Wu H, Shinkai Y, Irizarry RA, Feinberg AP (2009) Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat Genet 41:246–250

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • West AG, Fraser P (2005) Remote control of gene transcription. Hum Mol Genet 14 Spec No 1:R101–111

    Google Scholar 

  • Westhoff Smith D, Sugden B (2013) Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus. Viruses 5:226–240

    Article  PubMed  CAS  Google Scholar 

  • Winberg G, Matskova L, Chen F, Plant P, Rotin D, Gish G, Ingham R, Ernberg I, Pawson T (2000) Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases. Mol Cell Biol 20:8526–8535

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wolf H, zur Hausen H, Becker V (1973) EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nat New Biol 244:245–247

    Article  CAS  PubMed  Google Scholar 

  • Yao QY, Rickinson AB, Epstein MA (1985) A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int J Cancer 35:35–42

    Article  CAS  PubMed  Google Scholar 

  • Yao QY, Ogan P, Rowe M, Wood M, Rickinson AB (1989) Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers. Int J Cancer 43:67–71

    Article  CAS  PubMed  Google Scholar 

  • Yao QY, Rowe M, Martin B, Young LS, Rickinson AB (1991) The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers. J Gen Virol 72(Pt 7):1579–1590

    Article  CAS  PubMed  Google Scholar 

  • Young LS, Rickinson AB (2004) Epstein-Barr virus: 40 years on. Nat Rev Cancer 4:757–768

    Article  CAS  PubMed  Google Scholar 

  • Yu MC (1991) Nasopharyngeal carcinoma: epidemiology and dietary factors. IARC Sci Publ (105):39–47

    Google Scholar 

  • Zhao B, Zou J, Wang H, Johannsen E, Peng CW, Quackenbush J, Mar JC, Morton CC, Freedman ML, Blacklow SC, Aster JC, Bernstein BE, Kieff E (2011) Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth. Proc Natl Acad Sci U S A 108:14902–14907

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhao J, Liang Q, Cheung KF, Kang W, Lung RW, Tong JH, To KF, Sung JJ, Yu J (2013) Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells. Cancer 119:304–312

    Article  CAS  PubMed  Google Scholar 

  • zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, Santesson L (1970) EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228:1056–1058

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Box 280, 17177, Stockholm, Sweden

    Ingemar Ernberg

  2. Institute of Medical Microbiology and Hygiene, University of Regensburg, Franz-Josef-Strauss Allee 11, 93053, Regensburg, Germany

    Hans Helmut Niller

  3. Department of Oral Biology and Experimental Dental Research, University of Szeged, Tisza Lajos krt. 64, 6720, Szeged, Hungary

    Janos Minarovits

Authors
  1. Ingemar Ernberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hans Helmut Niller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Janos Minarovits
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Janos Minarovits .

Editor information

Editors and Affiliations

  1. Universität Erlangen, Institut für Klinische und molekulare Vi, Erlangen, Germany

    Walter Doerfler

  2. Biozentrum Köln, Universität zu Köln, Köln, Germany

    Petra Böhm

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Ernberg, I., Niller, H.H., Minarovits, J. (2016). Epigenetic Alterations of Viral and Cellular Genomes in EBV-Infected Cells. In: Doerfler, W., Böhm, P. (eds) Epigenetics - A Different Way of Looking at Genetics. Epigenetics and Human Health. Springer, Cham. https://doi.org/10.1007/978-3-319-27186-6_6

Download citation

Publish with us

Policies and ethics

Search

Navigation